PFIZER INC.

FORM 10 – K SUMMARY
Student name: Dang Thanh Thao
Keuka ID: 425041
______________________________
Pfizer applies science and its global resources to deliver therapies that extend and dramatically
improve people's lives, working across developed and emerging markets to advance the health of
people. health, prevention, treatment and cure to challenge the most feared diseases. One of the
things that impressed me about Pfizer is the purpose they set and followed from the beginning,
which is "Breakthroughs that change patients' lives. Our purpose fuels everything we do and
reflects both our passion for science and our commitment to patients". Biopharmaceutical
product manufacturing and sales account for the majority of their revenue. They think that
through improving illness treatment, enhancing health, wellness, and productivity, and reducing
other healthcare expenses like ER or hospital stays, their medications and vaccinations offer
substantial benefits to both patients and healthcare providers. It can be said that Pfizer always
puts product value and quality first in the research, development and innovation of each product.
Through this 2022 form 10-k, I do a SWOT analysis about Pfizer.

Strengths:
Robust R&D pipeline: Pfizer has been able to maintain a robust pipeline of cutting-edge
medications and treatments because of its dedication to research and development. Pfizer has
affirmed that "R&D is at the heart of fulfilling our purpose to deliver breakthroughs that change
patients' lives as we work to translate advanced science and technologies into the therapies that
may be the most impactful for patients". Increasing global R&D and pursuing strategies to
improve R&D productivity positions Pfizer on a sustainable roadmap that delivers results and
value in the short term.
Long-standing brand: It can be seen that Healthcare experts, patients, and investors hold a high
level of trust in the organization due to its lengthy history and dedication to quality and
innovation. Pfizer was incorporated under the laws of the State of Delaware on June 2, 1942.
Their operations are conducted globally, and they supply their medicines and vaccines to over
185 countries and territories.
Strong finances: Investing in businesses that are financially unstable may increase your risk of
suffering irreversible loss. Pfizer is a multinational pharmaceutical behemoth with around $50
billion in annual revenues (not including sales of COVID-19 products). Pfizer's average annual
revenue growth rate over the last three years has been 34.4%, outperforming 90.63% of the 918
firms in the Drug Manufacturers industry.
Weaknesses:
Competition: With the current social context, especially after the Covid - 19 pandemic, people
are increasingly interested in health care, so the pharmaceutical industry is of great interest,
which leads to fierce competition between companies in the industry. This requires Pfizer's
continuous research, development and product innovation to not fall behind other companies.
Patent expirations: Pfizer, like every pharmaceutical business, has to deal with the issue of its
blockbuster medications' patents expiring. Competitors may release generic versions of the
medications when patents expire, drastically cutting down sales of the original medicine. To
offset the effects of patent expirations, Pfizer must constantly innovate and create new
medications.
Regulatory and legal risks: Throughout the years, Pfizer has strived to vigorously protect its
patent rights against infringement, and it continues to support efforts to increase recognition of
patent rights worldwide while simultaneously Take the necessary steps to help ensure
appropriate patient access. If one of the patents relating to their products is found to be invalid by
a judicial, court or regulatory or administrative authority, the original products or biological
products Similar products may be introduced, leading to a decline in sales of Pfizer's existing
products.

Opportunities:
Market expansion: Pfizer's operations can be seen globally and they supply drugs and vaccines to
more than 185 countries and territories. Accordingly, emerging markets are a key component of
their global leadership strategy and their trade structure recognizes that the growing
demographics and economic power of emerging markets The fastest growth is becoming more
closely aligned with the characteristics found in developed markets. In particular, after the Covid
- 19 pandemic, developing countries with increasing health care needs bring great opportunities
for Pfizer. According to form 10-k, revenues from operations outside the U.S. of $57.9 billion
accounted for 58% of their total revenues in 2022.
Development cooperation: Pfizer can expand and broaden its range of products by means of
strategic alliances and acquisitions. Pfizer may increase its access to new technologies, broaden
its therapeutic areas, and fortify its R&D pipeline by partnering with or purchasing other
businesses.

Threats:
Patent expirations: The expiration of patents on important medications exposes Pfizer to
heightened competition from generic producers, resulting in a notable drop in sales of the
impacted items.
Pricing pressures: Pharmaceutical businesses are under more pressure to maintain low
healthcare costs as a result of increased scrutiny from governments, insurance companies, and
healthcare providers. Pfizer has to balance investing in research and development and preserving
profitability with navigating these pricing pressures.
Rivalry: Like I said, the pharmaceutical sector is known for its intense rivalry, as new treatments
and products are often being introduced to the market.
Legal and litigation risks: Pfizer is subject to the possibility of being sued or being involved in
litigation, especially when it comes to product responsibility, patent disputes, and antitrust issues.
Legal disputes can be expensive and time-consuming, and negative results could harm the
business's finances and reputation.